<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
	<id>https://ddn.pluspedia.org/w/index.php?action=history&amp;feed=atom&amp;title=Multiples_Myelom</id>
	<title>Multiples Myelom - Versionsgeschichte</title>
	<link rel="self" type="application/atom+xml" href="https://ddn.pluspedia.org/w/index.php?action=history&amp;feed=atom&amp;title=Multiples_Myelom"/>
	<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Multiples_Myelom&amp;action=history"/>
	<updated>2026-09-04T09:08:14Z</updated>
	<subtitle>Versionsgeschichte dieser Seite in PlusPedia</subtitle>
	<generator>MediaWiki 1.43.3</generator>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=Multiples_Myelom&amp;diff=42091&amp;oldid=prev</id>
		<title>Ossip Groth: Die Seite wurde neu angelegt: „Entstehender Artikel {| class=&quot;wikitable&quot; | | bgcolor=&quot;#dfdfdf&quot; | &#039;&#039;&#039;Siehe auch&#039;&#039;&#039; | align=&quot;left&quot; width=&quot;800&quot; | |- | bgcolor=&quot;#d…“</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=Multiples_Myelom&amp;diff=42091&amp;oldid=prev"/>
		<updated>2010-04-10T18:14:20Z</updated>

		<summary type="html">&lt;p&gt;Die Seite wurde neu angelegt: „&lt;a href=&quot;/wiki/Datei:Pptpdtjpg1.png&quot; title=&quot;Datei:Pptpdtjpg1.png&quot;&gt;miniatur|Entstehender Artikel&lt;/a&gt; {| class=&amp;quot;wikitable&amp;quot; | | bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Siehe auch&amp;#039;&amp;#039;&amp;#039; | align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; | |- | bgcolor=&amp;quot;#d…“&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Neue Seite&lt;/b&gt;&lt;/p&gt;&lt;div&gt;[[Datei:pptpdtjpg1.png|miniatur|Entstehender Artikel]]&lt;br /&gt;
{| class=&amp;quot;wikitable&amp;quot; |&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Siehe auch&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; |&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Freie Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot; |&lt;br /&gt;
&amp;lt;ref name=&amp;quot;PMID18245666&amp;quot;&amp;gt;Thalidomide for treatment of multiple myeloma: 10 years later. Blood 111(8):3968-77 (2008) PMID 18245666 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18332230&amp;quot;&amp;gt;Multiple myeloma. Blood 111(6):2962-72 (2008) PMID 18332230 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID17634408&amp;quot;&amp;gt;Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma. Blood 110(9):3112-21 (2007) PMID 17634408 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16917004&amp;quot;&amp;gt;Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. Blood 108(13):3992-6 (2006) PMID 16917004 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15090448&amp;quot;&amp;gt;Advances in biology of multiple myeloma: clinical applications. Blood 104(3):607-18 (2004) PMID 15090448 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12969978&amp;quot;&amp;gt;Treatment of multiple myeloma. Blood 103(1):20-32 (2004) PMID 12969978 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15194540&amp;quot;&amp;gt;Management of multiple myeloma and related-disorders: guidelines from the Italian Society of Hematology (SIE), Italian Society of Experimental Hematology (SIES) and Italian Group for Bone Marrow Transplantation (GITMO). Haematologica 89(6):717-41 (2004) PMID 15194540 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID10091392&amp;quot;&amp;gt;Treatment of multiple myeloma. Haematologica 84(1):36-58 (1999) PMID 10091392 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID20008242&amp;quot;&amp;gt;Novel therapies for relapsed myeloma. Hematology Am Soc Hematol Educ Program ():578-86 (2009) PMID 20008242 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID20008240&amp;quot;&amp;gt;How to treat a newly diagnosed young patient with multiple myeloma. Hematology Am Soc Hematol Educ Program ():555-65 (2009) PMID 20008240 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18024646&amp;quot;&amp;gt;The treatment of relapsed and refractory multiple myeloma. Hematology Am Soc Hematol Educ Program ():317-23 (2007) PMID 18024646 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID18024644&amp;quot;&amp;gt;Strategies for risk-adapted therapy in myeloma. Hematology Am Soc Hematol Educ Program ():304-10 (2007) PMID 18024644 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID15561686&amp;quot;&amp;gt;Multiple myeloma. Hematology Am Soc Hematol Educ Program ():237-56 (2004) PMID 15561686 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID14633785&amp;quot;&amp;gt;Advances in biology and therapy of multiple myeloma. Hematology Am Soc Hematol Educ Program ():248-78 (2003) PMID 14633785 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12446425&amp;quot;&amp;gt;Multiple myeloma. Hematology Am Soc Hematol Educ Program ():214-40 (2002) PMID 12446425 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID11722983&amp;quot;&amp;gt;Multiple myeloma. Hematology Am Soc Hematol Educ Program ():157-77 (2001) PMID 11722983 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16885408&amp;quot;&amp;gt;Multiple myeloma. J Am Soc Nephrol 17(9):2533-45 (2006) PMID 16885408 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID12354927&amp;quot;&amp;gt;Molecular aspects of multiple myeloma. Mol Pathol 55(5):273-83 (2002) PMID 12354927 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID16396976&amp;quot;&amp;gt;Myeloma--new approaches to combined nephrological-haematological management. Nephrol Dial Transplant 21(3):582-90 (2006) PMID 16396976 &amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;PMID8569099&amp;quot;&amp;gt;Acute myeloma kidney. Kidney Int 48(4):1347-61 (1995) PMID 8569099 &amp;lt;/ref&amp;gt;&lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Wichtige Übersichtsartikel&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Medline Suchterm/ Synonyme&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#00dfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Was ist das&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Struktur&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Physiologie&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Knockout&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Transgen&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Mutation&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Polymorphismus&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Genexpression&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Inhibitoren&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|-&lt;br /&gt;
| bgcolor=&amp;quot;#dfdfdf&amp;quot; | &amp;#039;&amp;#039;&amp;#039;Agonisten&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
| align=&amp;quot;left&amp;quot; width=&amp;quot;800&amp;quot;| &lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
----&lt;br /&gt;
&lt;br /&gt;
== Bibliographie ==&lt;br /&gt;
&amp;lt;references /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{LinkWP_Miniartikel|Txt=Multiples Myelom|Link=Multiples Myelom}}&lt;/div&gt;</summary>
		<author><name>Ossip Groth</name></author>
	</entry>
</feed>